BAY1817080
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAY1817080, covering 2022-08-18 to 2023-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb [Phase 2]